References
- Adang L.A., Pizzino A., Malhotra A., Dubbs H., Williams C., Sherbini O., et al.: Phenotypic and Imaging Spectrum Associated With WDR45. Pediatric Neurology, 2020, 109: 56–62.
- Chard M., Appendino J.P., Bello-Espinosa L.E., Curtis C., Rho J.M., Wei X.C., et al.: Single-center experience with Beta-propeller protein-associated neurodegeneration (BPAN); expanding the phenotypic spectrum. Molecular Genetics and Metabolism Reports, 2019, 20: 100483.
- Cong Y., So V., Tijssen M.A.J., Verbeek D.S., Reggiori F., Mauthe M.: WDR45, one gene associated with multiple neurodevelopmental disorders. Autophagy, 2021, 12: 1–16.
- Haack T.B., Hogarth P., Gregory A., Prokisch H., Hayflick S.J.: BPAN: the only X-linked dominant NBIA disorder. International Review of Neurobiology, 2013, 110: 85–90. doi: 10.1016/ B978-0-12-410502-7.00005-3
- Hayflick S.J., Kruer M.C., Gregory A., Haack T.B., Kurian M.A., Houlden H.H., et al.: Beta-propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain, 2013, 136: 1708–17.
- Ji C., Zhao H., Chen D., Zhang H., Zhao Y.G.: β-propeller proteins WDR45 and WDR45B regulate autophagosome maturation into autolysosomes in neural cells. Current Biology, 2021, 31: 1666–1677.e6.
- Li D., Roberts R.: WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases. Cell Mol Life Sci., 2001, 58(14): 2085–2097.
- Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., et al.: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 2015, 17: 405–424.
- Saitsu H., Nishimura T., Muramatsu K., Kodera H., Kumada S., Sugai K., et al.: De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat. Genet., 2013, 45: 445–449.
- Smith T.F: Diversity of WD-Repeat proteins. Subcell Biochem, 2008, 48: 20–30.
- Tello C., Darling A., Lupo V., Pérez-Dueñas B., Espinós C.: On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation. Clin. Genet., 2018, 93: 731–740.
- Wang Z.B., Liu J.Y., Xu X.J., Mao X.Y., Zhang W., Zhou H.H., et al.: Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation. Biomedicine & Pharmacotherapy, 2019, 118: 109068.
- Wilson J.L., Gregory A., Kurian M.A., Bushlin I., Mochel F., Emrick L., et al.: Consensus clinical management guideline for beta-propeller protein-associated neurodegeneration. Dev. Med. Child. Neurol., 2021, 63: 1402–1409.